🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

EPIGRAL vs IVP: Stock Comparison

EPIGRAL vs IVPUpdated 29 Oct 26, 4:08 PM ISTNSE & company filings

EPIGRAL is the larger company by market capitalisation. EPIGRAL shows a higher ROE, faster revenue growth and lower leverage, while IVP shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

EPIGRAL leads 7; IVP leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

EPIGRALIVP

Valuation lens

What price are you paying?

Market CapContext only
₹3,926 Cr
₹196 Cr
P/E RatioIVP has the lower reading
14.49x
9.2x ✓
P/B RatioIVP has the lower reading
1.77x
1.09x ✓
EPSEPIGRAL has the higher reading
₹23.12 ✓
₹13.58
Book ValueContext only
₹514.92
₹152.13
Dividend YieldIVP has the higher reading
0.55%
0.79% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
EPIGRAL is the larger company
₹3,926 Cr vs ₹196 Cr
P/E Ratio
IVP has a lower P/E
9.2x vs 14.49x
P/B Ratio
IVP has a lower P/B
1.09x vs 1.77x
EPS
EPIGRAL has higher earnings per share
₹23.12 vs ₹13.58
Dividend Yield
IVP has a higher dividend yield
0.79% vs 0.55%
Revenue Growth (TTM YoY)
EPIGRAL has faster revenue growth
17.3% vs 10.1%
EPS Growth (TTM YoY)
IVP has faster EPS growth
131.3% vs -6.8%
ROE
EPIGRAL has a higher ROE
14.99% vs 11.89%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricEPIGRALIVP
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricEPIGRALIVP
Live Price₹907.3₹190.45
Day Change0.54%-0.49%
Volume17,7006,794
52-Week High₹1,729.9₹247.95
52-Week Low₹807₹110
Distance from 52W High-47.55%-23.19%

Valuation

MetricEPIGRALIVP
Market Cap₹3,926 Cr₹196 Cr
P/E Ratio14.49x9.2x
P/B Ratio1.77x1.09x
EPS₹23.12₹13.58
Book Value₹514.92₹152.13
Dividend Yield0.55%0.79%

Growth

MetricEPIGRALIVP
Revenue Growth (TTM YoY)17.3%10.1%
EPS Growth (TTM YoY)-6.8%131.3%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricEPIGRALIVP
ROE14.99%11.89%
ROCE11.04%11.01%
Net Margin13.14%3.14%
Operating Margin16.37%5.47%
Debt to Equity0.25x0.42x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricEPIGRALIVP
Promoter Holding68.83%59.39%
FII Holding0.99%▼ 0.04 pp0.04%▲ 0.04 pp
DII Holding4.9%▼ 0.66 pp0.02%
Public Holding25.26%▲ 0.71 pp28.62%▼ 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: EPIGRAL and IVP.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.